Pilot study on recurrent aphthous stomatitis (RAS): a randomized placebo-controlled trial for the comparative therapeutic effects of systemic prednisone and systemic montelukast in subjects unresponsive to topical therapy
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
- Vol. 109 (3) , 402-407
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Montelukast inhibits neutrophil pro‐inflammatory activity by a cyclic AMP‐dependent mechanismBritish Journal of Pharmacology, 2008
- Levamisole can modulate the serum tumor necrosis factor‐α level in patients with recurrent aphthous ulcerationsJournal of Oral Pathology & Medicine, 2006
- Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2005
- Cysteinyl‐leukotrienes contribute to sputum eosinophil chemotactic activity in asthmaticsAllergy, 2005
- Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organsBurns, 2005
- The role of leukotrienes in allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2005
- Leukotriene Receptor Antagonists in Children with Cystic Fibrosis Lung DiseasePediatric Drugs, 2005
- Recurrent aphthous ulcers today: a review of the growing knowledgeInternational Journal of Oral and Maxillofacial Surgery, 2004
- Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist‐induced activation and retardation of apoptosisBritish Journal of Pharmacology, 2003
- Dapsone use with oral-genital ulcersBritish Journal of Dermatology, 1985